Loading...
Mangoceuticals, Inc.
MGRX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$1.73
$-0.02(-1.14%)
Mangoceuticals, Inc. (MGRX) AI-Powered Stock Analysis
See how Mangoceuticals, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMangoceuticals, Inc. (MGRX) Stock Overall Grade
Mangoceuticals, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
C+
Normal
Grade Breakdown by Metric
See how each financial and market factor contributes to Mangoceuticals, Inc.'s overall stock rating.
Forecast
C+Score
57/100Financial Growth
CScore
40/100Fundamental Growth
DScore
34/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
BScore
60/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Mangoceuticals, Inc. (MGRX) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 57/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (34/100, D) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Mangoceuticals, Inc. stock grade, including financials, comparisons, and forecasts.